Article info
PDFCorrespondence
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
- Correspondence to Dr Claudia Marques, Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil; claudia.reumatologia{at}gmail.com
Citation
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
Publication history
- Received June 21, 2020
- Accepted June 24, 2020
- First published July 13, 2020.
Online issue publication
October 18, 2023
Article Versions
- Previous version (18 October 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage